Ascorbic acid
Ascor, Berocca Pn, Infuvite, M.v.c. 9+, M.v.i, M.v.i. Lyophilized, Moviprep, Mvc, Plenvu, Vitaped (ascorbic acid) is a small molecule pharmaceutical. Ascorbic acid was first approved as M.v.i.-12 lyophilized on 1985-08-08. It is used to treat common cold, methemoglobinemia, penetrating wounds, scurvy, and tyrosinemias in the USA. It is known to target solute carrier family 23 member 2.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
infections | D007239 |
respiratory tract diseases | D012140 |
nervous system diseases | D009422 |
cardiovascular diseases | D002318 |
hemic and lymphatic diseases | D006425 |
hereditary congenital and neonatal diseases and abnormalities | D009358 |
nutritional and metabolic diseases | D009750 |
wounds and injuries | D014947 |
Trade Name
FDA
EMA
Ascor
CombinationsInfuvite, Moviprep, Plenvu (generic drugs available since 2012-01-25, discontinued: Berocca pn, M.v.c. 9+, M.v.i., M.v.i. lyophilized, Mvc, Vitaped)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Alpha-tocopherol acetate
+
Ascorbic acid
+
Biotin
+
Cholecalciferol
+
Cyanocobalamin
+
Dexpanthenol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a palmitate
+
Vitamin k
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
INFUVITE ADULT | Sandoz | N-021163 RX | 2000-05-18 | 2 products, RLD, RS |
Ascorbic acid
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ASCOR | McGuff Pharmaceuticals | N-209112 RX | 2017-10-02 | 1 products, RLD, RS |
Ascorbic acid
+
Biotin
+
Cholecalciferol
+
Cyanocobalamin
+
Dexpanthenol
+
Folic acid
+
Niacinamide
+
Pyridoxine
+
Riboflavin
+
Thiamine
+
Tocopherol acetate
+
Vitamin a
+
Vitamin k
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Phytonadione
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
M.V.I. PEDIATRIC | Hospira | N-018920 DISCN | 2000-09-21 | 1 products, RLD |
Hide discontinued
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine
+
Riboflavin 5'-phosphate sodium
+
Thiamine
+
Vitamin a
+
Vitamin e
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
M.V.I.-12 LYOPHILIZED | Teligent | N-018933 DISCN | 1985-08-08 | 1 products |
Hide discontinued
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
M.V.I.-12 ADULT | Hospira | N-008809 DISCN | 2004-04-22 | 1 products |
Hide discontinued
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
+
Vitamin k
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a palmitate
+
Vitamin e
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BEROCCA PN | Roche | N-006071 DISCN | 1985-10-10 | 1 products |
Hide discontinued
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pantothenic acid
+
Phytonadione
+
Pyridoxine
+
Riboflavin
+
Thiamine
+
Vitamin a palmitate
+
Vitamin e
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VITAPED | Hospira | N-020176 DISCN | 1993-12-29 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
adult infuvite multiple vitamins | New Drug Application | 2016-10-28 |
moviprep | New Drug Application | 2021-05-01 |
plenvu | New Drug Application | 2021-05-05 |
Agency Specific
FDA
EMA
Expiration | Code | ||
---|---|---|---|
ASCORBIC ACID, ASCOR, MCGUFF | |||
2024-10-02 | ODE-160 |
Patent Expiration
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Plenvu, Salix | |||
8999313 | 2033-09-10 | DP | |
9326969 | 2033-09-10 | U-2310 | |
9707297 | 2033-09-10 | DP | |
10016504 | 2033-09-10 | DP | |
10918723 | 2033-09-10 | U-2310 | |
9592252 | 2032-08-11 | DP | U-2310 |
10646512 | 2032-03-25 | DP | |
10780112 | 2032-03-09 | DP | |
10792306 | 2032-03-09 | DP | U-2310 |
11529368 | 2032-03-09 | DP | U-2310 |
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Moviprep, Salix Pharms | |||
7169381 | 2024-09-01 | DS, DP | |
7658914 | 2024-09-01 | DS, DP |
ATC Codes
A: Alimentary tract and metabolism drugs
— A11: Vitamins
— A11G: Ascorbic acid (vitamin c), incl. combinations
— A11GA: Vitamin c products, plain
— A11GA01: Ascorbic acid
— A11GB: Vitamin c combinations
— A11GB01: Ascorbic acid and calcium
G: Genito urinary system and sex hormones
— G01: Gynecological antiinfectives and antiseptics
— G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids
— G01AD: Organic acids, gynecological
— G01AD03: Ascorbic acid
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01X: Other ophthalmologicals in atc
— S01XA: Other ophthalmologicals in atc
— S01XA15: Ascorbic acid
HCPCS
No data
Clinical
Clinical Trials
56 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Fatigue | D005221 | HP_0012378 | R53.83 | 1 | 6 | 3 | 1 | 1 | 10 |
Obstructive sleep apnea | D020181 | EFO_0003918 | G47.33 | — | — | 5 | 1 | 1 | 7 |
Sleepiness | D000077260 | R40.0 | — | 1 | 3 | 2 | — | 5 | |
Schizophrenia | D012559 | EFO_0000692 | F20 | — | 2 | — | 1 | — | 3 |
Hepatitis c | D006526 | B19.2 | — | — | — | 1 | — | 1 | |
Dementia | D003704 | F03 | — | — | — | 1 | — | 1 | |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | — | — | — | 1 | — | 1 |
Menopause | D008593 | EFO_0003922 | N95 | — | — | — | 1 | — | 1 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | 1 | — | 1 |
Sleep wake disorders | D012893 | G47 | — | — | — | 1 | — | 1 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Narcolepsy | D009290 | EFO_0000614 | G47.4 | 1 | — | 4 | — | 1 | 6 |
Depression | D003863 | F33.9 | — | — | 4 | — | — | 4 | |
Disorders of excessive somnolence | D006970 | G47.1 | — | 1 | 3 | — | — | 3 | |
Sleep apnea syndromes | D012891 | EFO_0003877 | G47.3 | — | — | 2 | — | 1 | 3 |
Circadian rhythm sleep disorders | D020178 | G47.2 | — | — | 2 | — | 1 | 3 | |
Traumatic brain injuries | D000070642 | S06 | — | — | 2 | — | — | 2 | |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | 1 | — | — | 1 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 1 | 1 | — | — | 1 |
Nocturia | D053158 | R35.1 | — | 1 | 1 | — | — | 1 | |
Multiple myeloma | D009101 | C90.0 | — | — | 1 | — | — | 1 |
Show 3 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sleep initiation and maintenance disorders | D007319 | F51.01 | — | 2 | — | — | 1 | 3 | |
Glioma | D005910 | EFO_0000520 | — | 2 | — | — | — | 2 | |
Head and neck neoplasms | D006258 | 2 | 2 | — | — | — | 2 | ||
Healthy volunteers/patients | — | 2 | 1 | — | — | — | 2 | ||
Non-small-cell lung carcinoma | D002289 | 1 | 1 | — | — | — | 1 | ||
Sleep deprivation | D012892 | F51.12 | — | 1 | — | — | — | 1 | |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | — | — | — | 1 |
Paresis | D010291 | HP_0001269 | — | 1 | — | — | — | 1 | |
Esophageal neoplasms | D004938 | C15 | — | 1 | — | — | — | 1 | |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Show 5 more
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | — | — | 1 | 1 | |
Lung neoplasms | D008175 | C34.90 | — | — | — | — | 1 | 1 | |
Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | — | — | 1 | 1 |
B-cell lymphoma | D016393 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | ASCORBIC ACID |
INN | ascorbic acid |
Description | L-ascorbic acid is the L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate. It has a role as a coenzyme, a flour treatment agent, a food antioxidant, a plant metabolite, a cofactor, a skin lightening agent and a geroprotector. It is an ascorbic acid and a vitamin C. It is a conjugate acid of a L-ascorbate. It is an enantiomer of a D-ascorbic acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C1O[C@H]([C@@H](O)CO)C(O)=C1O |
Identifiers
PDB | — |
CAS-ID | 50-81-7 |
RxCUI | 1151 |
ChEMBL ID | CHEMBL196 |
ChEBI ID | 29073 |
PubChem CID | 54670067 |
DrugBank | DB00126 |
UNII ID | PQ6CK8PD0R (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
SLC23A2
SLC23A2
Organism
Homo sapiens
Gene name
SLC23A2
Gene synonyms
KIAA0238, NBTL1, SLC23A1, SVCT2, YSPL2
NCBI Gene ID
Protein name
solute carrier family 23 member 2
Protein synonyms
hSVCT2, Na(+)/L-ascorbic acid transporter 2, Nucleobase transporter-like 1 protein, Sodium-dependent vitamin C transporter 2, sodium-dependent vitamin C transporter-2, solute carrier family 23 (ascorbic acid transporter), member 2, solute carrier family 23 (nucleobase transporters), member 1, solute carrier family 23 (nucleobase transporters), member 2, testicular secretory protein Li 48, Yolk sac permease-like molecule 2
Uniprot ID
Mouse ortholog
Slc23a2 (54338)
solute carrier family 23 member 2 (Q9JM78)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 784 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
5,786 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more